Experts Endorsed SGLT2i Before GLP-1 RA in CKD and T2DM Tags CKD Diabetic Nephropathy GLP-1 agonists SGLT-2 Inhibitor Read more about Experts Endorsed SGLT2i Before GLP-1 RA in CKD and T2DM
GLP-1RAs Showed Favorable Liver Outcomes Signal in T2DM Tags MASLD/MASH GLP-1 agonists Read more about GLP-1RAs Showed Favorable Liver Outcomes Signal in T2DM
Injectable Semaglutide, Efpeglenatide Led MACE Profiles in T2DM Tags Coronary artery disease Stroke GLP-1 agonists Read more about Injectable Semaglutide, Efpeglenatide Led MACE Profiles in T2DM
Synthetic Semaglutide Showed Noninferior Glycemic Control vs Reference Semaglutide Tags FBS GLP-1 agonists PLBS hBA1c Read more about Synthetic Semaglutide Showed Noninferior Glycemic Control vs Reference Semaglutide
GLP-1RAs and SGLT2 Inhibitors Showed Favorable Liver Outcomes in T2DM Tags GLP-1 agonists MASLD/MASH SGLT-2 Inhibitor Thiazolidinediones Read more about GLP-1RAs and SGLT2 Inhibitors Showed Favorable Liver Outcomes in T2DM
Combined BP and Diabetes Therapy Improved CV Outcomes in Meta-analysis Tags ASCVD Coronary artery disease GLP-1 agonists Myocardial infarction Read more about Combined BP and Diabetes Therapy Improved CV Outcomes in Meta-analysis
GIP Infusion Did Not Improve Glycemic Control in Type 2 Diabetes Tags GLP-1 agonists Read more about GIP Infusion Did Not Improve Glycemic Control in Type 2 Diabetes
Safety Profiles Differed Across SGLT2i, GLP-1 RA, and DPP-4i Tags DPP-4 inhibitors GLP-1 agonists SGLT-2 Inhibitor Read more about Safety Profiles Differed Across SGLT2i, GLP-1 RA, and DPP-4i
Semaglutide Improved Insulin Sensitivity in Adolescents With Obesity Tags GLP-1 agonists Read more about Semaglutide Improved Insulin Sensitivity in Adolescents With Obesity
Semaglutide Shows Reassuring Safety Signal After Dialysis Initiation Tags GLP-1 agonists Read more about Semaglutide Shows Reassuring Safety Signal After Dialysis Initiation